to assess minimal stent diameter and area (MSD and MSA). Stent expansion was defined as MSD (or MSA) divided by the values predicted by the manufacturers' compliance charts. Patients were divided into 4 groups according to the median values of arc and area of calcium. Results: Mean stent expansion was 73.3 AE 8.7% for MSD and 65.2 AE 12.0% for MSA. Stent expansion defined by MSD was significantly different among the groups (p ¼ 0.02) (Figure). Similar trend was observed for stent expansion defined by MSA (p ¼ 0.16).
Background: To examine the endothelial shear stress (ESS) patterns, the neointimal distribution and the relation between ESS and neointimal thickness (NT) in models derived from the integration of frequency domain optical coherence tomographic (FD-OCT) and coronary angiographic data and compare these estimations with those computed in the traditional reconstructions obtained by the fusion of intravascular ultrasound (IVUS) and coronary angiography. Methods: Six segments implanted with an Absorb Bioresorbable Vascular Scaffold (Absorb BVS) that were investigated with FD-OCT and IVUS examination at baseline and 6 or 12 months follow-up were included. The IVUS and OCT data acquired at follow-up were fused separately with the angiographic data to reconstruct the luminal surface at baseline and follow-up. Blood flow simulation was performed on the baseline IVUS-based and OCT-based models and computational fluid dynamics techniques were implemented to assess the ESS and the association between the ESS and the measured NT at follow-up. Results: The IVUS-based models appeared to underestimate the neointima tissue (0.67AE0.59 mm3 vs. 15.14AE5.63 mm3, P¼0.001) compared to the FD-OCT-based reconstructions. Flow recirculation zones were detected in the FD-OCT-based reconstructions and the ESS values were lower compared to the IVUS-based models (1.29AE0.66 Pa vs. 1.87AE0.66 Pa, P¼0.030). These differences should be attributed to the poor resolution of IVUS that did not allow visualization of the protruded struts. A statistically significant inverse correlation was noted between the logarithmic ESS at baseline and the NT at follow-up in all the FD-OCT-based models which was higher than the correlation reported in 5 of the 6 IVUS-derived models (mean correlation coefficient: -0.52AE0.19 vs. -0.10AE0.04, P¼0.028).
Conclusions: It appears that the models derived by the fusion of IVUS and coronary angiography cannot provide enough detail and are incapable of assessing the microenvironment and its effect on neointima formation following an Absorb BVS implantation. FD-OCT reconstruction appears superior to IVUS-based reconstructions and it should be preferred for studying the effect of ESS on neointimal proliferation. Thoraxcenter, Erasmus MC, N/A Background: The aim of this study is to examine the implications of the local endothelial shear stress (ESS) on neointimal proliferation following an Absorb Bioresorbable Vascular Scaffold (BVS) implantation. Methods: Twelve patients who had an Absorb BVS implantation in a stenotic, relatively straight arterial segment and who were investigated with serial optical coherence tomographic examination at baseline and 1 year follow-up were included in the current analysis. The optical coherence tomographic data acquired at follow-up were used to reconstruct the treated segment. Blood flow simulation was performed on the luminal surface at baseline defined by the Absorb BVS struts and the estimated ESS was related to the neointima thickness measured at 1year follow-up. Results: The protruded struts appeared to affect the ESS patterns. Low ESS and recirculation zones were noted between the struts areas and high ESS zones on the top of the struts. At baseline, , 61% of the measured ESS were <1 Pa. At follow-up, the mean neointima thickness was 113AE45 mm while the percentage area obstruction was 13.1AE6.6%. A weak but statistically significant inverse correlation was noted between baseline ESS and neointima thickness at 1year follow-up in all studied segments (correlation coefficient range: -0.110 to -0.620). Mixed linear regression analysis between baseline ESS and neointima thickness at follow-up yielded a slope of -29 mm/Pa and a y-intercept of 142 mm.
Conclusions:
The hemodynamic micro-environment appears to regulate neointimal response following an Absorb BVS implantation. These findings underline the role of the ESS patterns on vessel wall healing and should be taken into consideration in the design of bioresorbable devices.
TCT-565
OCT evaluation of the time course of vessel healing following implantation of new generation biodegradable polymer-coated and sirolimus-eluting cobaltchromium coronary stent system (ALEX OCT Study). Background: Biodegradable stent coatings are hoped to improve the vessel wall healing. ALEX is a new generation, biodegradable polymer-coated, sirolimus-eluting, cobalt-chromium coronary stent system. Methods: A prospective, single arm, multi-centre registry enrolled 60 patients with de novo native coronary lesions treated with ALEX stent and examined the outcomes by quantitative coronary analysis (QCA) and optical coherence tomography (OCT) at multiple timepoints (3 subgroups of 20 patients each at 3, 6 and 12 months) to capture the time course of vessel healing. Stent strut coverage, stent apposition and neointimal proliferation were assessed by OCT. Safety endpoint was the composite of death, myocardial infarction, target lesion re-intervention (TLR) and stent thrombosis (ST) at 30 days and 12 month follow-up. Results: At baseline, reference vessel diameter was 2.85 (IQR 2.45, 3.17) mm, lesion length was 12.00 (IQR 9.67,14.58), minimal lumen diameter was 1.02AE0.40 mm and percent diameter stenosis (%DS) was 65AE11.5 by QCA. We have treated 31% of lesions type A/B1 and 69% of lesions type B2/C. Median stent diameter was 3.0 (IQR 2.75, 3.50) mm, stent length was 15 (IQR 12; 20) mm. Procedural device success rate was 98,7% with post-procedural %DS 6.0 (IQR 2.0; 8.5). QCA analysis revealed median late lumen loss (mm) 0.035 (IQR -0.047, 0.01) at 3 months, 0.17 (IQR -0.01, 0.32) at 6 months, and 0.14 (IQR 0.07, 0.42) at 12 months. The OCT analysis presented full strut coverage in 96% at 3 months, in 98% at 6 months, and 100% at 12 months. The rate of uncovered stent struts per section (RUST) >0.3 was 3.15% at 3 months, 1.74% at 6 months, and 0% at 12 months of follow-up, and the malapposition rate was 0.13%, 0.03% and 0.02%, respectively. There was one death (1,7%), one TLR (1,7%) and no definite ST at 12th months of follow-up. Conclusions: Biodegradable polymer-coated, sirolimus-eluting ALEX stent appears to feature very favourable profile of arterial wall healing already at 3 months post TUESDAY, OCTOBER 29, 2013, 3:30 PM-5:30 PM Addenbrooke's Hospital, Cambridge, United Kingdom Background: Angiographically-identified geographical miss (GM) of atherosclerotic plaques during percutaneous coronary intervention (PCI) is common. However, the relationship between GM and the underlying plaque as identified by virtual histology intravascular ultrasound (VH-IVUS) as not been studied. We aimed to determine whether GM is associated with specific plaque characteristics, PCI-related myocardial infarction (MI4a) and future major adverse cardiovascular events (MACE). Methods: Patients with stable angina (n¼100) or myocardial infarction (MI) (n¼70) underwent 3-vessel VH-IVUS prior to PCI. GM was defined as 3 uncovered VH-IVUS frames in stented lesions with plaque area >40% at either stent edge. MACE comprised death, MI, hospitalization with unstable angina or unplanned revascularization. Results: 30372mm VH-IVUS and 1096 lesions were analysed: 858 (78.2%) plaques were unstented, 165 (15.1%) stented without GM, and 80 (7.3%) stented with GM. GM was associated with increased plaque volume, necrotic core %, dense calcium % and VH-defined thin cap fibroatheroma (VHTCFA) and with reduced fibrous tissue % (table). GM was not associated with increased MI4a (33 (54%) vs. 71 (72%), p¼0.15) or inflammatory cytokine release. MACE (n¼43) occurred in 28 patients over a median follow-up of 1115 days. MACE were directly linked to 11/858 (0.8%) unstented plaques, 7/165 (4.2%) fully covered stented lesions and 8/80 (10%) stented lesions with GM (log rank p<0.001). In patients presenting with MI, stented lesions with GM had increased future MACE compared to fully covered lesions (log rank p¼0.015).
Conclusions: GM is associated with larger plaques with a more vulnerable composition and type and with future MACE in MI patients undergoing PCI. Whether the association of GM with future MACE is independent of adverse plaque anatomy is not clear and requires a much larger study to determine.
TCT-567
Comparison Wakayama Medical University, wakayama, Japan
Background: Implantation of drug-eluting stents (DES) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) reduces in-stent restenosis compared with bare metal stents (BMS), however, the long-term risk of DES use in STEMI has been pointed. Previous pathological and optical coherence tomography (OCT) study reported that first generation DES use in STEMI resulted in higher rates of uncovered and malapposed stent struts at follow-up. The long-term safety of second generation everolimus-eluting stents (EES) use in STEMI remains unknown. We used OCT to examine vascular response including strut coverage and malapposition in patients with STEMI treated with EES and BMS. Methods: We enrolled 85 patients with STEMI who underwent primary stenting and 10-month follow-up OCT (EES: 47 patients and BMS 38 patients).
Results: A total of 18244 stent struts were analyzed. There were no significant differences in the percentage of uncovered and malapposed stent struts per lesion between 2 stents (2.28AE3.08% versus 1.47AE2.46%, P¼0.182 and 0.57AE1.22% versus 0.41AE0.84%,P¼0.499, respectively). Averaged neointimal thickness was smaller in EES lesions (103 AE 38 mm vs. 385 AE 151 mm, P<0.001). Intra-stent thrombus was observed in 12.8% of EES lesions and 10.5% of BMS lesions (p ¼ 0.750). Conclusions: In STEMI patients undergoing primary PCI, there are no significant differences in the percentage of uncovered and malapposed stent struts, and the incidence of intra-stent thrombus at 10-month follow-up between EES and BMS. On the other hands, EES as compared with BMS significantly reduces neointimal hyperplasia. EES has a potential to achieve low late loss without sacrificing safety. Osaka Police Hospital, Osaka, Japan Background: Slow flow or no re-flow phenomenon during coronary intervention is mainly caused by distal embolization of thrombus and plaque debris, and is associated with unfavorable long-term clinical outcomes. This phenomenon often occurs in the patients with acute coronary syndrome (ACS) but also in some patients with stable angina. However, the high-risk patients of distal embolization are not well understood. Methods: Consecutive patients with acute myocardial infarction (AMI) (n¼192), those with unstable angina (UA) (n¼89), and those with stable coronary heart disease (CHD) (n¼211) who received coronary intervention with filter-type distal protection device (Filtrap) were prospectively enrolled. We compared between the groups the frequency of filter slow flow/ no-reflow phenomenon and of distal embolization captured by the filter device. We examined by angioscopy if ruptured plaque was present at the target lesion and analyzed its association with filter slow flow/ no re-flow phenomenon or distal embolization. Results: Filter slow flow/ no re-flow phenomenon occurred most frequently in AMI patients, although there was no difference between UA and CHD patients (43% vs. 20% vs. 18%, P<0.001). Filter slow flow/ no re-flow phenomenon occurred more frequently in the patients with vs. without ruptured plaque in each patient group (AMI patients: 79% vs. 8%, P<0.001; UA patients: 57% vs. 7%, P¼0.001; CHD patients: 72% vs. 6%, P<0.001). Among the patients without ruptured plaque, the incidence was not different between the patient groups. Conclusions: Although AMI patients are at high risk of filter slow flow/ no re-flow phenomenon and of distal embolization than UA or CHD patients, the risk was associated with the presence of ruptured plaque. Patients with ruptured plaque had the higher risk than those without it regardless of the diagnosis. www.jacctctabstracts2013.com TUESDAY, OCTOBER 29, 2013, 3:30 PM-5:30 PM 
